Is intermittent antiretroviral therapy a satisfactory strategy for the management of patients living with HIV?
AIDS Rev. 2021 Apr 12. doi: 10.24875/AIDSRev.20000108. Online ahead of print.ABSTRACTMany innovations, such as long-acting agents, new delivery modalities (injectable and nanoparticles), and novel paradigms (immunotherapy or dual therapy), have been introduced to facilitate the administration of antiretroviral treatment (ART) to patients infected with HIV and improve their adherence and quality of life without altering the drugs' effectiveness. Studies have investigated the use of intermittent treatment, especially weekends-off ART in HIV-suppressed patients. In this review, we analyzed data concerning intermittent ART to ...
Source: AIDS Reviews - April 12, 2021 Category: Infectious Diseases Authors: Thomas Roland Jean C Yombi Source Type: research

Is intermittent antiretroviral therapy a satisfactory strategy for the management of patients living with HIV?
AIDS Rev. 2021 Apr 12. doi: 10.24875/AIDSRev.20000108. Online ahead of print.ABSTRACTMany innovations, such as long-acting agents, new delivery modalities (injectable and nanoparticles), and novel paradigms (immunotherapy or dual therapy), have been introduced to facilitate the administration of antiretroviral treatment (ART) to patients infected with HIV and improve their adherence and quality of life without altering the drugs' effectiveness. Studies have investigated the use of intermittent treatment, especially weekends-off ART in HIV-suppressed patients. In this review, we analyzed data concerning intermittent ART to ...
Source: AIDS Reviews - April 12, 2021 Category: Infectious Diseases Authors: Thomas Roland Jean C Yombi Source Type: research

Is intermittent antiretroviral therapy a satisfactory strategy for the management of patients living with HIV?
AIDS Rev. 2021 Apr 12. doi: 10.24875/AIDSRev.20000108. Online ahead of print.ABSTRACTMany innovations, such as long-acting agents, new delivery modalities (injectable and nanoparticles), and novel paradigms (immunotherapy or dual therapy), have been introduced to facilitate the administration of antiretroviral treatment (ART) to patients infected with HIV and improve their adherence and quality of life without altering the drugs' effectiveness. Studies have investigated the use of intermittent treatment, especially weekends-off ART in HIV-suppressed patients. In this review, we analyzed data concerning intermittent ART to ...
Source: AIDS Reviews - April 12, 2021 Category: Infectious Diseases Authors: Thomas Roland Jean C Yombi Source Type: research

Is intermittent antiretroviral therapy a satisfactory strategy for the management of patients living with HIV?
AIDS Rev. 2021 Apr 12. doi: 10.24875/AIDSRev.20000108. Online ahead of print.ABSTRACTMany innovations, such as long-acting agents, new delivery modalities (injectable and nanoparticles), and novel paradigms (immunotherapy or dual therapy), have been introduced to facilitate the administration of antiretroviral treatment (ART) to patients infected with HIV and improve their adherence and quality of life without altering the drugs' effectiveness. Studies have investigated the use of intermittent treatment, especially weekends-off ART in HIV-suppressed patients. In this review, we analyzed data concerning intermittent ART to ...
Source: AIDS Reviews - April 12, 2021 Category: Infectious Diseases Authors: Thomas Roland Jean C Yombi Source Type: research

Is intermittent antiretroviral therapy a satisfactory strategy for the management of patients living with HIV?
AIDS Rev. 2021 Apr 12. doi: 10.24875/AIDSRev.20000108. Online ahead of print.ABSTRACTMany innovations, such as long-acting agents, new delivery modalities (injectable and nanoparticles), and novel paradigms (immunotherapy or dual therapy), have been introduced to facilitate the administration of antiretroviral treatment (ART) to patients infected with HIV and improve their adherence and quality of life without altering the drugs' effectiveness. Studies have investigated the use of intermittent treatment, especially weekends-off ART in HIV-suppressed patients. In this review, we analyzed data concerning intermittent ART to ...
Source: AIDS Reviews - April 12, 2021 Category: Infectious Diseases Authors: Thomas Roland Jean C Yombi Source Type: research

Is intermittent antiretroviral therapy a satisfactory strategy for the management of patients living with HIV?
AIDS Rev. 2021 Apr 12. doi: 10.24875/AIDSRev.20000108. Online ahead of print.ABSTRACTMany innovations, such as long-acting agents, new delivery modalities (injectable and nanoparticles), and novel paradigms (immunotherapy or dual therapy), have been introduced to facilitate the administration of antiretroviral treatment (ART) to patients infected with HIV and improve their adherence and quality of life without altering the drugs' effectiveness. Studies have investigated the use of intermittent treatment, especially weekends-off ART in HIV-suppressed patients. In this review, we analyzed data concerning intermittent ART to ...
Source: AIDS Reviews - April 12, 2021 Category: Infectious Diseases Authors: Thomas Roland Jean C Yombi Source Type: research

Is intermittent antiretroviral therapy a satisfactory strategy for the management of patients living with HIV?
AIDS Rev. 2021 Apr 12. doi: 10.24875/AIDSRev.20000108. Online ahead of print.ABSTRACTMany innovations, such as long-acting agents, new delivery modalities (injectable and nanoparticles), and novel paradigms (immunotherapy or dual therapy), have been introduced to facilitate the administration of antiretroviral treatment (ART) to patients infected with HIV and improve their adherence and quality of life without altering the drugs' effectiveness. Studies have investigated the use of intermittent treatment, especially weekends-off ART in HIV-suppressed patients. In this review, we analyzed data concerning intermittent ART to ...
Source: AIDS Reviews - April 12, 2021 Category: Infectious Diseases Authors: Thomas Roland Jean C Yombi Source Type: research

Is intermittent antiretroviral therapy a satisfactory strategy for the management of patients living with HIV?
AIDS Rev. 2021 Apr 12. doi: 10.24875/AIDSRev.20000108. Online ahead of print.ABSTRACTMany innovations, such as long-acting agents, new delivery modalities (injectable and nanoparticles), and novel paradigms (immunotherapy or dual therapy), have been introduced to facilitate the administration of antiretroviral treatment (ART) to patients infected with HIV and improve their adherence and quality of life without altering the drugs' effectiveness. Studies have investigated the use of intermittent treatment, especially weekends-off ART in HIV-suppressed patients. In this review, we analyzed data concerning intermittent ART to ...
Source: AIDS Reviews - April 12, 2021 Category: Infectious Diseases Authors: Thomas Roland Jean C Yombi Source Type: research

Is intermittent antiretroviral therapy a satisfactory strategy for the management of patients living with HIV?
AIDS Rev. 2021 Apr 12. doi: 10.24875/AIDSRev.20000108. Online ahead of print.ABSTRACTMany innovations, such as long-acting agents, new delivery modalities (injectable and nanoparticles), and novel paradigms (immunotherapy or dual therapy), have been introduced to facilitate the administration of antiretroviral treatment (ART) to patients infected with HIV and improve their adherence and quality of life without altering the drugs' effectiveness. Studies have investigated the use of intermittent treatment, especially weekends-off ART in HIV-suppressed patients. In this review, we analyzed data concerning intermittent ART to ...
Source: AIDS Reviews - April 12, 2021 Category: Infectious Diseases Authors: Thomas Roland Jean C Yombi Source Type: research

Is intermittent antiretroviral therapy a satisfactory strategy for the management of patients living with HIV?
AIDS Rev. 2021 Apr 12. doi: 10.24875/AIDSRev.20000108. Online ahead of print.ABSTRACTMany innovations, such as long-acting agents, new delivery modalities (injectable and nanoparticles), and novel paradigms (immunotherapy or dual therapy), have been introduced to facilitate the administration of antiretroviral treatment (ART) to patients infected with HIV and improve their adherence and quality of life without altering the drugs' effectiveness. Studies have investigated the use of intermittent treatment, especially weekends-off ART in HIV-suppressed patients. In this review, we analyzed data concerning intermittent ART to ...
Source: AIDS Reviews - April 12, 2021 Category: Infectious Diseases Authors: Thomas Roland Jean C Yombi Source Type: research

Is intermittent antiretroviral therapy a satisfactory strategy for the management of patients living with HIV?
AIDS Rev. 2021 Apr 12. doi: 10.24875/AIDSRev.20000108. Online ahead of print.ABSTRACTMany innovations, such as long-acting agents, new delivery modalities (injectable and nanoparticles), and novel paradigms (immunotherapy or dual therapy), have been introduced to facilitate the administration of antiretroviral treatment (ART) to patients infected with HIV and improve their adherence and quality of life without altering the drugs' effectiveness. Studies have investigated the use of intermittent treatment, especially weekends-off ART in HIV-suppressed patients. In this review, we analyzed data concerning intermittent ART to ...
Source: AIDS Reviews - April 12, 2021 Category: Infectious Diseases Authors: Thomas Roland Jean C Yombi Source Type: research

Is intermittent antiretroviral therapy a satisfactory strategy for the management of patients living with HIV?
AIDS Rev. 2021 Apr 12. doi: 10.24875/AIDSRev.20000108. Online ahead of print.ABSTRACTMany innovations, such as long-acting agents, new delivery modalities (injectable and nanoparticles), and novel paradigms (immunotherapy or dual therapy), have been introduced to facilitate the administration of antiretroviral treatment (ART) to patients infected with HIV and improve their adherence and quality of life without altering the drugs' effectiveness. Studies have investigated the use of intermittent treatment, especially weekends-off ART in HIV-suppressed patients. In this review, we analyzed data concerning intermittent ART to ...
Source: AIDS Reviews - April 12, 2021 Category: Infectious Diseases Authors: Thomas Roland Jean C Yombi Source Type: research

Is intermittent antiretroviral therapy a satisfactory strategy for the management of patients living with HIV?
AIDS Rev. 2021 Apr 12. doi: 10.24875/AIDSRev.20000108. Online ahead of print.ABSTRACTMany innovations, such as long-acting agents, new delivery modalities (injectable and nanoparticles), and novel paradigms (immunotherapy or dual therapy), have been introduced to facilitate the administration of antiretroviral treatment (ART) to patients infected with HIV and improve their adherence and quality of life without altering the drugs' effectiveness. Studies have investigated the use of intermittent treatment, especially weekends-off ART in HIV-suppressed patients. In this review, we analyzed data concerning intermittent ART to ...
Source: AIDS Reviews - April 12, 2021 Category: Infectious Diseases Authors: Thomas Roland Jean C Yombi Source Type: research

Is intermittent antiretroviral therapy a satisfactory strategy for the management of patients living with HIV?
AIDS Rev. 2021 Apr 12. doi: 10.24875/AIDSRev.20000108. Online ahead of print.ABSTRACTMany innovations, such as long-acting agents, new delivery modalities (injectable and nanoparticles), and novel paradigms (immunotherapy or dual therapy), have been introduced to facilitate the administration of antiretroviral treatment (ART) to patients infected with HIV and improve their adherence and quality of life without altering the drugs' effectiveness. Studies have investigated the use of intermittent treatment, especially weekends-off ART in HIV-suppressed patients. In this review, we analyzed data concerning intermittent ART to ...
Source: AIDS Reviews - April 12, 2021 Category: Infectious Diseases Authors: Thomas Roland Jean C Yombi Source Type: research

Is intermittent antiretroviral therapy a satisfactory strategy for the management of patients living with HIV?
AIDS Rev. 2021 Apr 12. doi: 10.24875/AIDSRev.20000108. Online ahead of print.ABSTRACTMany innovations, such as long-acting agents, new delivery modalities (injectable and nanoparticles), and novel paradigms (immunotherapy or dual therapy), have been introduced to facilitate the administration of antiretroviral treatment (ART) to patients infected with HIV and improve their adherence and quality of life without altering the drugs' effectiveness. Studies have investigated the use of intermittent treatment, especially weekends-off ART in HIV-suppressed patients. In this review, we analyzed data concerning intermittent ART to ...
Source: AIDS Reviews - April 12, 2021 Category: Infectious Diseases Authors: Thomas Roland Jean C Yombi Source Type: research

Is intermittent antiretroviral therapy a satisfactory strategy for the management of patients living with HIV?
AIDS Rev. 2021 Apr 12. doi: 10.24875/AIDSRev.20000108. Online ahead of print.ABSTRACTMany innovations, such as long-acting agents, new delivery modalities (injectable and nanoparticles), and novel paradigms (immunotherapy or dual therapy), have been introduced to facilitate the administration of antiretroviral treatment (ART) to patients infected with HIV and improve their adherence and quality of life without altering the drugs' effectiveness. Studies have investigated the use of intermittent treatment, especially weekends-off ART in HIV-suppressed patients. In this review, we analyzed data concerning intermittent ART to ...
Source: AIDS Reviews - April 12, 2021 Category: Infectious Diseases Authors: Thomas Roland Jean C Yombi Source Type: research

Is intermittent antiretroviral therapy a satisfactory strategy for the management of patients living with HIV?
AIDS Rev. 2021 Apr 12. doi: 10.24875/AIDSRev.20000108. Online ahead of print.ABSTRACTMany innovations, such as long-acting agents, new delivery modalities (injectable and nanoparticles), and novel paradigms (immunotherapy or dual therapy), have been introduced to facilitate the administration of antiretroviral treatment (ART) to patients infected with HIV and improve their adherence and quality of life without altering the drugs' effectiveness. Studies have investigated the use of intermittent treatment, especially weekends-off ART in HIV-suppressed patients. In this review, we analyzed data concerning intermittent ART to ...
Source: AIDS Reviews - April 12, 2021 Category: Infectious Diseases Authors: Thomas Roland Jean C Yombi Source Type: research

Is intermittent antiretroviral therapy a satisfactory strategy for the management of patients living with HIV?
AIDS Rev. 2021 Apr 12. doi: 10.24875/AIDSRev.20000108. Online ahead of print.ABSTRACTMany innovations, such as long-acting agents, new delivery modalities (injectable and nanoparticles), and novel paradigms (immunotherapy or dual therapy), have been introduced to facilitate the administration of antiretroviral treatment (ART) to patients infected with HIV and improve their adherence and quality of life without altering the drugs' effectiveness. Studies have investigated the use of intermittent treatment, especially weekends-off ART in HIV-suppressed patients. In this review, we analyzed data concerning intermittent ART to ...
Source: AIDS Reviews - April 12, 2021 Category: Infectious Diseases Authors: Thomas Roland Jean C Yombi Source Type: research

Is intermittent antiretroviral therapy a satisfactory strategy for the management of patients living with HIV?
AIDS Rev. 2021 Apr 12. doi: 10.24875/AIDSRev.20000108. Online ahead of print.ABSTRACTMany innovations, such as long-acting agents, new delivery modalities (injectable and nanoparticles), and novel paradigms (immunotherapy or dual therapy), have been introduced to facilitate the administration of antiretroviral treatment (ART) to patients infected with HIV and improve their adherence and quality of life without altering the drugs' effectiveness. Studies have investigated the use of intermittent treatment, especially weekends-off ART in HIV-suppressed patients. In this review, we analyzed data concerning intermittent ART to ...
Source: AIDS Reviews - April 12, 2021 Category: Infectious Diseases Authors: Thomas Roland Jean C Yombi Source Type: research

Is intermittent antiretroviral therapy a satisfactory strategy for the management of patients living with HIV?
AIDS Rev. 2021 Apr 12. doi: 10.24875/AIDSRev.20000108. Online ahead of print.ABSTRACTMany innovations, such as long-acting agents, new delivery modalities (injectable and nanoparticles), and novel paradigms (immunotherapy or dual therapy), have been introduced to facilitate the administration of antiretroviral treatment (ART) to patients infected with HIV and improve their adherence and quality of life without altering the drugs' effectiveness. Studies have investigated the use of intermittent treatment, especially weekends-off ART in HIV-suppressed patients. In this review, we analyzed data concerning intermittent ART to ...
Source: AIDS Reviews - April 12, 2021 Category: Infectious Diseases Authors: Thomas Roland Jean C Yombi Source Type: research

Is intermittent antiretroviral therapy a satisfactory strategy for the management of patients living with HIV?
AIDS Rev. 2021 Apr 12. doi: 10.24875/AIDSRev.20000108. Online ahead of print.ABSTRACTMany innovations, such as long-acting agents, new delivery modalities (injectable and nanoparticles), and novel paradigms (immunotherapy or dual therapy), have been introduced to facilitate the administration of antiretroviral treatment (ART) to patients infected with HIV and improve their adherence and quality of life without altering the drugs' effectiveness. Studies have investigated the use of intermittent treatment, especially weekends-off ART in HIV-suppressed patients. In this review, we analyzed data concerning intermittent ART to ...
Source: AIDS Reviews - April 12, 2021 Category: Infectious Diseases Authors: Thomas Roland Jean C Yombi Source Type: research

Is intermittent antiretroviral therapy a satisfactory strategy for the management of patients living with HIV?
AIDS Rev. 2021 Apr 12. doi: 10.24875/AIDSRev.20000108. Online ahead of print.ABSTRACTMany innovations, such as long-acting agents, new delivery modalities (injectable and nanoparticles), and novel paradigms (immunotherapy or dual therapy), have been introduced to facilitate the administration of antiretroviral treatment (ART) to patients infected with HIV and improve their adherence and quality of life without altering the drugs' effectiveness. Studies have investigated the use of intermittent treatment, especially weekends-off ART in HIV-suppressed patients. In this review, we analyzed data concerning intermittent ART to ...
Source: AIDS Reviews - April 12, 2021 Category: Infectious Diseases Authors: Thomas Roland Jean C Yombi Source Type: research

Is intermittent antiretroviral therapy a satisfactory strategy for the management of patients living with HIV?
AIDS Rev. 2021 Apr 12. doi: 10.24875/AIDSRev.20000108. Online ahead of print.ABSTRACTMany innovations, such as long-acting agents, new delivery modalities (injectable and nanoparticles), and novel paradigms (immunotherapy or dual therapy), have been introduced to facilitate the administration of antiretroviral treatment (ART) to patients infected with HIV and improve their adherence and quality of life without altering the drugs' effectiveness. Studies have investigated the use of intermittent treatment, especially weekends-off ART in HIV-suppressed patients. In this review, we analyzed data concerning intermittent ART to ...
Source: AIDS Reviews - April 12, 2021 Category: Infectious Diseases Authors: Thomas Roland Jean C Yombi Source Type: research

Is intermittent antiretroviral therapy a satisfactory strategy for the management of patients living with HIV?
AIDS Rev. 2021 Apr 12. doi: 10.24875/AIDSRev.20000108. Online ahead of print.ABSTRACTMany innovations, such as long-acting agents, new delivery modalities (injectable and nanoparticles), and novel paradigms (immunotherapy or dual therapy), have been introduced to facilitate the administration of antiretroviral treatment (ART) to patients infected with HIV and improve their adherence and quality of life without altering the drugs' effectiveness. Studies have investigated the use of intermittent treatment, especially weekends-off ART in HIV-suppressed patients. In this review, we analyzed data concerning intermittent ART to ...
Source: AIDS Reviews - April 12, 2021 Category: Infectious Diseases Authors: Thomas Roland Jean C Yombi Source Type: research

Is intermittent antiretroviral therapy a satisfactory strategy for the management of patients living with HIV?
AIDS Rev. 2021 Apr 12. doi: 10.24875/AIDSRev.20000108. Online ahead of print.ABSTRACTMany innovations, such as long-acting agents, new delivery modalities (injectable and nanoparticles), and novel paradigms (immunotherapy or dual therapy), have been introduced to facilitate the administration of antiretroviral treatment (ART) to patients infected with HIV and improve their adherence and quality of life without altering the drugs' effectiveness. Studies have investigated the use of intermittent treatment, especially weekends-off ART in HIV-suppressed patients. In this review, we analyzed data concerning intermittent ART to ...
Source: AIDS Reviews - April 12, 2021 Category: Infectious Diseases Authors: Thomas Roland Jean C Yombi Source Type: research

Current situation and prospect of HIV-associated neurocognitive disorder research in China: Epidemiology, research, diagnosis, and treatment status
AIDS Rev. 2021 Mar 24. doi: 10.24875/AIDSRev.20000044. Online ahead of print.ABSTRACTStandards of HIV/AIDS prevention and control in some areas of China are still poor. People live longer with the use of therapeutic drugs, which may lead to an increase in the number of HIV-associated neurocognitive disorders (HAND). However, only a few multicenter and large-scale studies investigating the prevalence and incidence of HAND have been undertaken in China. While the number of HIV/AIDS cases in China is still large, the prevalence of HAND is remains unclear. The diagnosis of HAND in China is mainly based on the international dia...
Source: AIDS Reviews - March 24, 2021 Category: Infectious Diseases Authors: Yu Qi A Ailixire Yu-Xun Gao Rui-Li Li Hong-Jun Li Source Type: research

Current situation and prospect of HIV-associated neurocognitive disorder research in China: Epidemiology, research, diagnosis, and treatment status
AIDS Rev. 2021 Mar 24. doi: 10.24875/AIDSRev.20000044. Online ahead of print.ABSTRACTStandards of HIV/AIDS prevention and control in some areas of China are still poor. People live longer with the use of therapeutic drugs, which may lead to an increase in the number of HIV-associated neurocognitive disorders (HAND). However, only a few multicenter and large-scale studies investigating the prevalence and incidence of HAND have been undertaken in China. While the number of HIV/AIDS cases in China is still large, the prevalence of HAND is remains unclear. The diagnosis of HAND in China is mainly based on the international dia...
Source: AIDS Reviews - March 24, 2021 Category: Infectious Diseases Authors: Yu Qi A Ailixire Yu-Xun Gao Rui-Li Li Hong-Jun Li Source Type: research

Current situation and prospect of HIV-associated neurocognitive disorder research in China: Epidemiology, research, diagnosis, and treatment status
AIDS Rev. 2021 Mar 24. doi: 10.24875/AIDSRev.20000044. Online ahead of print.ABSTRACTStandards of HIV/AIDS prevention and control in some areas of China are still poor. People live longer with the use of therapeutic drugs, which may lead to an increase in the number of HIV-associated neurocognitive disorders (HAND). However, only a few multicenter and large-scale studies investigating the prevalence and incidence of HAND have been undertaken in China. While the number of HIV/AIDS cases in China is still large, the prevalence of HAND is remains unclear. The diagnosis of HAND in China is mainly based on the international dia...
Source: AIDS Reviews - March 24, 2021 Category: Infectious Diseases Authors: Yu Qi A Ailixire Yu-Xun Gao Rui-Li Li Hong-Jun Li Source Type: research

Current situation and prospect of HIV-associated neurocognitive disorder research in China: Epidemiology, research, diagnosis, and treatment status
AIDS Rev. 2021 Mar 24. doi: 10.24875/AIDSRev.20000044. Online ahead of print.ABSTRACTStandards of HIV/AIDS prevention and control in some areas of China are still poor. People live longer with the use of therapeutic drugs, which may lead to an increase in the number of HIV-associated neurocognitive disorders (HAND). However, only a few multicenter and large-scale studies investigating the prevalence and incidence of HAND have been undertaken in China. While the number of HIV/AIDS cases in China is still large, the prevalence of HAND is remains unclear. The diagnosis of HAND in China is mainly based on the international dia...
Source: AIDS Reviews - March 24, 2021 Category: Infectious Diseases Authors: Yu Qi A Ailixire Yu-Xun Gao Rui-Li Li Hong-Jun Li Source Type: research

Current situation and prospect of HIV-associated neurocognitive disorder research in China: Epidemiology, research, diagnosis, and treatment status
AIDS Rev. 2021 Mar 24. doi: 10.24875/AIDSRev.20000044. Online ahead of print.ABSTRACTStandards of HIV/AIDS prevention and control in some areas of China are still poor. People live longer with the use of therapeutic drugs, which may lead to an increase in the number of HIV-associated neurocognitive disorders (HAND). However, only a few multicenter and large-scale studies investigating the prevalence and incidence of HAND have been undertaken in China. While the number of HIV/AIDS cases in China is still large, the prevalence of HAND is remains unclear. The diagnosis of HAND in China is mainly based on the international dia...
Source: AIDS Reviews - March 24, 2021 Category: Infectious Diseases Authors: Yu Qi A Ailixire Yu-Xun Gao Rui-Li Li Hong-Jun Li Source Type: research

Current situation and prospect of HIV-associated neurocognitive disorder research in China: Epidemiology, research, diagnosis, and treatment status
AIDS Rev. 2021 Mar 24. doi: 10.24875/AIDSRev.20000044. Online ahead of print.ABSTRACTStandards of HIV/AIDS prevention and control in some areas of China are still poor. People live longer with the use of therapeutic drugs, which may lead to an increase in the number of HIV-associated neurocognitive disorders (HAND). However, only a few multicenter and large-scale studies investigating the prevalence and incidence of HAND have been undertaken in China. While the number of HIV/AIDS cases in China is still large, the prevalence of HAND is remains unclear. The diagnosis of HAND in China is mainly based on the international dia...
Source: AIDS Reviews - March 24, 2021 Category: Infectious Diseases Authors: Yu Qi A Ailixire Yu-Xun Gao Rui-Li Li Hong-Jun Li Source Type: research

Current situation and prospect of HIV-associated neurocognitive disorder research in China: Epidemiology, research, diagnosis, and treatment status
AIDS Rev. 2021 Mar 24. doi: 10.24875/AIDSRev.20000044. Online ahead of print.ABSTRACTStandards of HIV/AIDS prevention and control in some areas of China are still poor. People live longer with the use of therapeutic drugs, which may lead to an increase in the number of HIV-associated neurocognitive disorders (HAND). However, only a few multicenter and large-scale studies investigating the prevalence and incidence of HAND have been undertaken in China. While the number of HIV/AIDS cases in China is still large, the prevalence of HAND is remains unclear. The diagnosis of HAND in China is mainly based on the international dia...
Source: AIDS Reviews - March 24, 2021 Category: Infectious Diseases Authors: Yu Qi A Ailixire Yu-Xun Gao Rui-Li Li Hong-Jun Li Source Type: research

Current situation and prospect of HIV-associated neurocognitive disorder research in China: Epidemiology, research, diagnosis, and treatment status
AIDS Rev. 2021 Mar 24. doi: 10.24875/AIDSRev.20000044. Online ahead of print.ABSTRACTStandards of HIV/AIDS prevention and control in some areas of China are still poor. People live longer with the use of therapeutic drugs, which may lead to an increase in the number of HIV-associated neurocognitive disorders (HAND). However, only a few multicenter and large-scale studies investigating the prevalence and incidence of HAND have been undertaken in China. While the number of HIV/AIDS cases in China is still large, the prevalence of HAND is remains unclear. The diagnosis of HAND in China is mainly based on the international dia...
Source: AIDS Reviews - March 24, 2021 Category: Infectious Diseases Authors: Yu Qi A Ailixire Yu-Xun Gao Rui-Li Li Hong-Jun Li Source Type: research

Current situation and prospect of HIV-associated neurocognitive disorder research in China: Epidemiology, research, diagnosis, and treatment status
AIDS Rev. 2021 Mar 24. doi: 10.24875/AIDSRev.20000044. Online ahead of print.ABSTRACTStandards of HIV/AIDS prevention and control in some areas of China are still poor. People live longer with the use of therapeutic drugs, which may lead to an increase in the number of HIV-associated neurocognitive disorders (HAND). However, only a few multicenter and large-scale studies investigating the prevalence and incidence of HAND have been undertaken in China. While the number of HIV/AIDS cases in China is still large, the prevalence of HAND is remains unclear. The diagnosis of HAND in China is mainly based on the international dia...
Source: AIDS Reviews - March 24, 2021 Category: Infectious Diseases Authors: Yu Qi A Ailixire Yu-Xun Gao Rui-Li Li Hong-Jun Li Source Type: research

Current situation and prospect of HIV-associated neurocognitive disorder research in China: Epidemiology, research, diagnosis, and treatment status
AIDS Rev. 2021 Mar 24. doi: 10.24875/AIDSRev.20000044. Online ahead of print.ABSTRACTStandards of HIV/AIDS prevention and control in some areas of China are still poor. People live longer with the use of therapeutic drugs, which may lead to an increase in the number of HIV-associated neurocognitive disorders (HAND). However, only a few multicenter and large-scale studies investigating the prevalence and incidence of HAND have been undertaken in China. While the number of HIV/AIDS cases in China is still large, the prevalence of HAND is remains unclear. The diagnosis of HAND in China is mainly based on the international dia...
Source: AIDS Reviews - March 24, 2021 Category: Infectious Diseases Authors: Yu Qi A Ailixire Yu-Xun Gao Rui-Li Li Hong-Jun Li Source Type: research

Current situation and prospect of HIV-associated neurocognitive disorder research in China: Epidemiology, research, diagnosis, and treatment status
AIDS Rev. 2021 Mar 24. doi: 10.24875/AIDSRev.20000044. Online ahead of print.ABSTRACTStandards of HIV/AIDS prevention and control in some areas of China are still poor. People live longer with the use of therapeutic drugs, which may lead to an increase in the number of HIV-associated neurocognitive disorders (HAND). However, only a few multicenter and large-scale studies investigating the prevalence and incidence of HAND have been undertaken in China. While the number of HIV/AIDS cases in China is still large, the prevalence of HAND is remains unclear. The diagnosis of HAND in China is mainly based on the international dia...
Source: AIDS Reviews - March 24, 2021 Category: Infectious Diseases Authors: Yu Qi A Ailixire Yu-Xun Gao Rui-Li Li Hong-Jun Li Source Type: research

Current situation and prospect of HIV-associated neurocognitive disorder research in China: Epidemiology, research, diagnosis, and treatment status
AIDS Rev. 2021 Mar 24. doi: 10.24875/AIDSRev.20000044. Online ahead of print.ABSTRACTStandards of HIV/AIDS prevention and control in some areas of China are still poor. People live longer with the use of therapeutic drugs, which may lead to an increase in the number of HIV-associated neurocognitive disorders (HAND). However, only a few multicenter and large-scale studies investigating the prevalence and incidence of HAND have been undertaken in China. While the number of HIV/AIDS cases in China is still large, the prevalence of HAND is remains unclear. The diagnosis of HAND in China is mainly based on the international dia...
Source: AIDS Reviews - March 24, 2021 Category: Infectious Diseases Authors: Yu Qi A Ailixire Yu-Xun Gao Rui-Li Li Hong-Jun Li Source Type: research

Current situation and prospect of HIV-associated neurocognitive disorder research in China: Epidemiology, research, diagnosis, and treatment status
AIDS Rev. 2021 Mar 24. doi: 10.24875/AIDSRev.20000044. Online ahead of print.ABSTRACTStandards of HIV/AIDS prevention and control in some areas of China are still poor. People live longer with the use of therapeutic drugs, which may lead to an increase in the number of HIV-associated neurocognitive disorders (HAND). However, only a few multicenter and large-scale studies investigating the prevalence and incidence of HAND have been undertaken in China. While the number of HIV/AIDS cases in China is still large, the prevalence of HAND is remains unclear. The diagnosis of HAND in China is mainly based on the international dia...
Source: AIDS Reviews - March 24, 2021 Category: Infectious Diseases Authors: Yu Qi A Ailixire Yu-Xun Gao Rui-Li Li Hong-Jun Li Source Type: research

Current situation and prospect of HIV-associated neurocognitive disorder research in China: Epidemiology, research, diagnosis, and treatment status
AIDS Rev. 2021 Mar 24. doi: 10.24875/AIDSRev.20000044. Online ahead of print.ABSTRACTStandards of HIV/AIDS prevention and control in some areas of China are still poor. People live longer with the use of therapeutic drugs, which may lead to an increase in the number of HIV-associated neurocognitive disorders (HAND). However, only a few multicenter and large-scale studies investigating the prevalence and incidence of HAND have been undertaken in China. While the number of HIV/AIDS cases in China is still large, the prevalence of HAND is remains unclear. The diagnosis of HAND in China is mainly based on the international dia...
Source: AIDS Reviews - March 24, 2021 Category: Infectious Diseases Authors: Yu Qi A Ailixire Yu-Xun Gao Rui-Li Li Hong-Jun Li Source Type: research

New SARS-CoV-2 Variants Challenge Vaccines Protection
AIDS Rev. 2021 Feb 22;23(1):57-58. doi: 10.24875/AIDSRev.M21000040.NO ABSTRACTPMID:33750742 | DOI:10.24875/AIDSRev.M21000040 (Source: AIDS Reviews)
Source: AIDS Reviews - March 22, 2021 Category: Infectious Diseases Authors: Vicente Soriano Jos é V Fernández-Montero Source Type: research

New SARS-CoV-2 Variants Challenge Vaccines Protection
AIDS Rev. 2021 Feb 22;23(1):57-58. doi: 10.24875/AIDSRev.M21000040.NO ABSTRACTPMID:33750742 | DOI:10.24875/AIDSRev.M21000040 (Source: AIDS Reviews)
Source: AIDS Reviews - March 22, 2021 Category: Infectious Diseases Authors: Vicente Soriano Jos é V Fernández-Montero Source Type: research

New SARS-CoV-2 Variants Challenge Vaccines Protection
AIDS Rev. 2021 Feb 22;23(1):57-58. doi: 10.24875/AIDSRev.M21000040.NO ABSTRACTPMID:33750742 | DOI:10.24875/AIDSRev.M21000040 (Source: AIDS Reviews)
Source: AIDS Reviews - March 22, 2021 Category: Infectious Diseases Authors: Vicente Soriano Jos é V Fernández-Montero Source Type: research

A Systematic Review of Magnetic Resonance Imaging Studies in Perinatally HIV-Infected Individuals
AIDS Rev. 2021 Mar 18. doi: 10.24875/AIDSRev.20000088. Online ahead of print.ABSTRACTOver the past few years, neuroimaging studies have been performed in young adults with perinatally acquired HIV (PHIV) to study the impact of HIV infection on the central nervous system (CNS), but no recent review have been published. This review aims to identify brain areas where PHIV eems to have greater impact taking into account demographic, behavioral, and clinical characteristics in PHIV infected patients. For this purpose, PubMed and Medline searches were carried out which included studies from 2010 to April 2020. We performed a sys...
Source: AIDS Reviews - March 18, 2021 Category: Infectious Diseases Authors: Manuela Mart ín-Bejarano Beatriz Ruiz-Saez Ana Martinez-de-Arag ón Helena Melero Berta Zamora Norberto A Malpica Jose T Ramos Maria I Gonzalez-Tom é Source Type: research

A Systematic Review of Magnetic Resonance Imaging Studies in Perinatally HIV-Infected Individuals
AIDS Rev. 2021 Mar 18. doi: 10.24875/AIDSRev.20000088. Online ahead of print.ABSTRACTOver the past few years, neuroimaging studies have been performed in young adults with perinatally acquired HIV (PHIV) to study the impact of HIV infection on the central nervous system (CNS), but no recent review have been published. This review aims to identify brain areas where PHIV eems to have greater impact taking into account demographic, behavioral, and clinical characteristics in PHIV infected patients. For this purpose, PubMed and Medline searches were carried out which included studies from 2010 to April 2020. We performed a sys...
Source: AIDS Reviews - March 18, 2021 Category: Infectious Diseases Authors: Manuela Mart ín-Bejarano Beatriz Ruiz-Saez Ana Martinez-de-Arag ón Helena Melero Berta Zamora Norberto A Malpica Jose T Ramos Maria I Gonzalez-Tom é Source Type: research

A Systematic Review of Magnetic Resonance Imaging Studies in Perinatally HIV-Infected Individuals
AIDS Rev. 2021 Mar 18. doi: 10.24875/AIDSRev.20000088. Online ahead of print.ABSTRACTOver the past few years, neuroimaging studies have been performed in young adults with perinatally acquired HIV (PHIV) to study the impact of HIV infection on the central nervous system (CNS), but no recent review have been published. This review aims to identify brain areas where PHIV eems to have greater impact taking into account demographic, behavioral, and clinical characteristics in PHIV infected patients. For this purpose, PubMed and Medline searches were carried out which included studies from 2010 to April 2020. We performed a sys...
Source: AIDS Reviews - March 18, 2021 Category: Infectious Diseases Authors: Manuela Mart ín-Bejarano Beatriz Ruiz-Saez Ana Martinez-de-Arag ón Helena Melero Berta Zamora Norberto A Malpica Jose T Ramos Maria I Gonzalez-Tom é Source Type: research

How Does HIV Persist Under Antiretroviral Therapy: A Review of the Evidence
AIDS Rev. 2021 Mar 16. doi: 10.24875/AIDSRev.21000004. Online ahead of print.ABSTRACTHIV-1 is a retrovirus capable of establishing viral reservoirs that remain stable for extended periods under suppressive antiretroviral therapy (ART). Immune dysfunction and latency are well known to contribute to this longevity, but the respective roles of viral replication and latently infected (LI) cell proliferation under suppressive antiretroviral therapy (ART) have long been controversial. This historical review critically appraises the body of evidence regarding possible viral replication and proliferation of infected cells under AR...
Source: AIDS Reviews - March 16, 2021 Category: Infectious Diseases Authors: Gregory D Howgego Source Type: research

How Does HIV Persist Under Antiretroviral Therapy: A Review of the Evidence
AIDS Rev. 2021 Mar 16. doi: 10.24875/AIDSRev.21000004. Online ahead of print.ABSTRACTHIV-1 is a retrovirus capable of establishing viral reservoirs that remain stable for extended periods under suppressive antiretroviral therapy (ART). Immune dysfunction and latency are well known to contribute to this longevity, but the respective roles of viral replication and latently infected (LI) cell proliferation under suppressive antiretroviral therapy (ART) have long been controversial. This historical review critically appraises the body of evidence regarding possible viral replication and proliferation of infected cells under AR...
Source: AIDS Reviews - March 16, 2021 Category: Infectious Diseases Authors: Gregory D Howgego Source Type: research

How Does HIV Persist Under Antiretroviral Therapy: A Review of the Evidence
AIDS Rev. 2021 Mar 16. doi: 10.24875/AIDSRev.21000004. Online ahead of print.ABSTRACTHIV-1 is a retrovirus capable of establishing viral reservoirs that remain stable for extended periods under suppressive antiretroviral therapy (ART). Immune dysfunction and latency are well known to contribute to this longevity, but the respective roles of viral replication and latently infected (LI) cell proliferation under suppressive antiretroviral therapy (ART) have long been controversial. This historical review critically appraises the body of evidence regarding possible viral replication and proliferation of infected cells under AR...
Source: AIDS Reviews - March 16, 2021 Category: Infectious Diseases Authors: Gregory D Howgego Source Type: research

Cellular and Immune Therapy for Treating HIV-1 Infection
AIDS Rev. 2021 Feb 24. doi: 10.24875/AIDSRev.20000110. Online ahead of print.ABSTRACTHIV-1 infection has caused a number of deaths worldwide and remains a global health concern. Combined antiretroviral therapy (cART) inhibits viral replication, prevents CD4+ T cell loss, and thus slows HIV disease progression. However, cART does not eradicate HIV-1. Infected individuals must remain on treatment for their entire lives and treatment interruption will result in viral rebound.PMID:33626034 | DOI:10.24875/AIDSRev.20000110 (Source: AIDS Reviews)
Source: AIDS Reviews - February 24, 2021 Category: Infectious Diseases Authors: Wei Li Qiqiang Zhou Lingbo Xia Ruixiang Zou Wei Zou Source Type: research

Cellular and Immune Therapy for Treating HIV-1 Infection
AIDS Rev. 2021 Feb 24. doi: 10.24875/AIDSRev.20000110. Online ahead of print.ABSTRACTHIV-1 infection has caused a number of deaths worldwide and remains a global health concern. Combined antiretroviral therapy (cART) inhibits viral replication, prevents CD4+ T cell loss, and thus slows HIV disease progression. However, cART does not eradicate HIV-1. Infected individuals must remain on treatment for their entire lives and treatment interruption will result in viral rebound.PMID:33626034 | DOI:10.24875/AIDSRev.20000110 (Source: AIDS Reviews)
Source: AIDS Reviews - February 24, 2021 Category: Infectious Diseases Authors: Wei Li Qiqiang Zhou Lingbo Xia Ruixiang Zou Wei Zou Source Type: research